Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients.

Tong, Nora; Kumar, Aalok; Gelowitz, Gerald; Tinker, Anna; Holloway, Caroline; Ko, Jenny

Tong, Nora; Kumar, Aalok; Gelowitz, Gerald; Tinker, Anna; Holloway, Caroline; Ko, Jenny.

Afiliação

Tong N; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Kumar A; Department of Medical Oncology, British Columbia (BC) Cancer - Surrey, Surrey, BC, Canada.
Gelowitz G; Department of Radiation Oncology, British Columbia (BC) Cancer - Abbotsford, Abbotsford, BC, Canada.
Tinker A; Department of Medical Oncology, British Columbia (BC) Cancer - Vancouver, Vancouver, BC, Canada.
Holloway C; Department of Radiation Oncology, British Columbia (BC) Cancer - Victoria, Victoria, BC, Canada.
Ko J; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Front Oncol ; 13: 1035511, 2023.

Article em En | MEDLINE | ID: mdl-37091159

Palavras-chave

chemotherapy; endometrial neoplasms; gynecology; radiotherapy; uterine cancer; uterine neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google